Long-term treatment-free remission (TFR) following frontline (1L) nilotinib in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP): ENESTfreedom 144-wk results.
暂无分享，去创建一个
J. Radich | S. Acharyya | F. Giles | G. Saglio | S. Chaturvedi | A. Hochhaus | T. Masszi | N. Gattermann | B. Martino | E. Conneally | A. Hellmann | S. Saussele | D. Ross | J. Stentoft | M. T. G. Casares | V. Bédoucha | M. Sondhi | P. L. Coutre | V. Gutiérrez